Article
Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
Circulation - 26 Jun 2001
Westrick R J, Bodary P F, Xu Z, Shen Y C, Broze G J, Eitzman D T
Abstract excerpt
BACKGROUND: Tissue factor initiates blood coagulation after atherosclerotic plaque disruption. Tissue factor pathway inhibitor (TFPI) inhibits tissue factor activity and may reduce thrombus formation in this setting. We evaluated the effect of heterozygous TFPI deficiency on the development of atherosclerosis and thrombosis in atherosclerosis-prone mice. METHODS AND RESULTS: Mice with a combined heterozygous TFPI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
